These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31734290)

  • 1. Perampanel attenuates epileptiform phenotype in C6 glioma.
    Mayer J; Kirschstein T; Resch T; Porath K; Krause BJ; Köhling R; Lange F
    Neurosci Lett; 2020 Jan; 715():134629. PubMed ID: 31734290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMPA receptor antagonist perampanel affects glioblastoma cell growth and glutamate release in vitro.
    Lange F; Weßlau K; Porath K; Hörnschemeyer MF; Bergner C; Krause BJ; Mullins CS; Linnebacher M; Köhling R; Kirschstein T
    PLoS One; 2019; 14(2):e0211644. PubMed ID: 30716120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perampanel Add-on to Standard Radiochemotherapy
    Lange F; Hartung J; Liebelt C; Boisserée J; Resch T; Porath K; Hörnschemeyer MF; Reichart G; Sellmann T; Neubert V; Kriesen S; Hildebrandt G; Schültke E; Köhling R; Kirschstein T
    Front Neurosci; 2020; 14():598266. PubMed ID: 33328869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seizures and Tumor Progression in Glioma Patients with Uncontrollable Epilepsy Treated with Perampanel.
    Izumoto S; Miyauchi M; Tasaki T; Okuda T; Nakagawa N; Nakano N; Kato A; Fujita M
    Anticancer Res; 2018 Jul; 38(7):4361-4366. PubMed ID: 29970574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The AMPA receptor antagonist NBQX exerts anti-seizure but not antiepileptogenic effects in the intrahippocampal kainate mouse model of mesial temporal lobe epilepsy.
    Twele F; Bankstahl M; Klein S; Römermann K; Löscher W
    Neuropharmacology; 2015 Aug; 95():234-42. PubMed ID: 25839899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perampanel, an antagonist of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors, for the treatment of epilepsy: studies in human epileptic brain and nonepileptic brain and in rodent models.
    Zwart R; Sher E; Ping X; Jin X; Sims JR; Chappell AS; Gleason SD; Hahn PJ; Gardinier K; Gernert DL; Hobbs J; Smith JL; Valli SN; Witkin JM
    J Pharmacol Exp Ther; 2014 Oct; 351(1):124-33. PubMed ID: 25027316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of calcium-permeable and calcium-impermeable AMPA receptors by perampanel in rat brain neurons.
    Barygin OI
    Neurosci Lett; 2016 Oct; 633():146-151. PubMed ID: 27663136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propofol inhibits invasion and proliferation of C6 glioma cells by regulating the Ca
    Wang XY; Li YL; Wang HY; Zhu M; Guo D; Wang GL; Gao YT; Yang Z; Li T; Yang CY; Chen YM
    Toxicol In Vitro; 2017 Oct; 44():57-65. PubMed ID: 28663055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perampanel chronic treatment does not induce tolerance and decreases tolerance to clobazam in genetically epilepsy prone rats.
    Citraro R; De Sarro C; Leo A; Donato di Paola E; Palma E; Russo E; De Sarro G
    Epilepsy Res; 2018 Oct; 146():94-102. PubMed ID: 30092489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience of Low Dose Perampanel to Add-on in Glioma Patients with Levetiracetam-uncontrollable Epilepsy.
    Chonan M; Saito R; Kanamori M; Osawa SI; Watanabe M; Suzuki H; Nakasato N; Tominaga T
    Neurol Med Chir (Tokyo); 2020 Jan; 60(1):37-44. PubMed ID: 31748440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perampanel but Not Amantadine Prevents Behavioral Alterations and Epileptogenesis in Pilocarpine Rat Model of Status Epilepticus.
    Mohammad H; Sekar S; Wei Z; Moien-Afshari F; Taghibiglou C
    Mol Neurobiol; 2019 Apr; 56(4):2508-2523. PubMed ID: 30039334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perampanel and decanoic acid show synergistic action against AMPA receptors and seizures.
    Augustin K; Williams S; Cunningham M; Devlin AM; Friedrich M; Jayasekera A; Hussain MA; Holliman D; Mitchell P; Jenkins A; Chen PE; Walker MC; Williams RSB
    Epilepsia; 2018 Nov; 59(11):e172-e178. PubMed ID: 30324610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seizure response to perampanel in drug-resistant epilepsy with gliomas: early observations.
    Vecht C; Duran-Peña A; Houillier C; Durand T; Capelle L; Huberfeld G
    J Neurooncol; 2017 Jul; 133(3):603-607. PubMed ID: 28492978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The discovery and development of perampanel for the treatment of epilepsy.
    Hanada T
    Expert Opin Drug Discov; 2014 Apr; 9(4):449-58. PubMed ID: 24559052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissection of mitogenic and neurodegenerative actions of cystine and glutamate in malignant gliomas.
    Savaskan NE; Seufert S; Hauke J; Tränkle C; Eyüpoglu IY; Hahnen E
    Oncogene; 2011 Jan; 30(1):43-53. PubMed ID: 20802520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perampanel inhibits calcitonin gene-related peptide release from rat brainstem in vitro.
    Tringali G; Currò D; Navarra P
    J Headache Pain; 2018 Nov; 19(1):107. PubMed ID: 30419806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perampanel as monotherapy and adjunctive therapy for focal onset seizures, focal to bilateral tonic-clonic seizures and as adjunctive therapy of generalized onset tonic-clonic seizures.
    Tyrlikova I; Brazdil M; Rektor I; Tyrlik M
    Expert Rev Neurother; 2019 Jan; 19(1):5-16. PubMed ID: 30560703
    [No Abstract]   [Full Text] [Related]  

  • 18. Adjunctive perampanel for glioma-associated epilepsy.
    Dunn-Pirio AM; Woodring S; Lipp E; Herndon JE; Healy P; Weant M; Randazzo D; Desjardins A; Friedman HS; Peters KB
    Epilepsy Behav Case Rep; 2018; 10():114-117. PubMed ID: 30377587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Noncompetitive AMPAR Antagonist Perampanel Abrogates Brain Endothelial Cell Permeability in Response to Ischemia: Involvement of Claudin-5.
    Lv JM; Guo XM; Chen B; Lei Q; Pan YJ; Yang Q
    Cell Mol Neurobiol; 2016 Jul; 36(5):745-53. PubMed ID: 26306919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergism of perampanel and zonisamide in the rat amygdala kindling model of temporal lobe epilepsy.
    Russmann V; Salvamoser JD; Rettenbeck ML; Komori T; Potschka H
    Epilepsia; 2016 Apr; 57(4):638-47. PubMed ID: 26854031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.